News

July 20, 2020

Pharmascience International expands its global reach with its first products to market in Central and Eastern Europe (CEE) region

Latest Corporate News

 

 

July 20th, 2020, Montreal, Canada. In 2019, Pharmascience made significant investments to strategically expand its market in Central and Eastern Europe. Pharmascience will be commercializing high quality generics under its own brand name, through strategic wholesale and distribution partnerships in CEE. As the fastest growing region globally with an expected growth of 6.9% by 2022, the CEE Region represents an exciting expansion opportunity for Pharmascience’s International division, which enhances brand visibility for both the division and flagship Pharmascience brand.

Pharmascience has since launched its first products in Bulgaria and Albania, providing patients with innovative Oncology and CNS formulations as well as quality generic products.

 

Mainly focusing on high quality Oncology generics, Pharmascience’s expansion plan for the next year in CEE include the launch of 10 major products in 8 countries, with more to come in the years to follow.

 

Pharmascience is increasingly focused on establishing a solid presence in the region. The strategic market expansion in CEE is driven by Pharmascience International’s local team in Sofia, Bulgaria.

 

 

About Pharmascience

 

Founded in 1983, Pharmascience Inc. is one of the largest pharmaceutical manufacturers in Canada with over 1,500 employees, and an international presence spanning 60 countries. Pharmascience’s global presence and agile business development model provides patients and healthcare communities around the world with the same quality medicines as are dispensed in Canada. Its R&D team has the extensive expertise necessary for the development of complex injectable and solid oral generic drugs.

 

Pharmascience has been distributing high-quality, FDA certified generic products in the US since 2017 from our Candiac site. Since its inception in 1983, Pharmascience has invested over $500M in research and development and ranks amongst the top generic manufacturers in Canada, offering over 300 product families in more than 20 dosage forms.  In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.

 

For media inquiries

Andrea Frascione
Communications Manager
Tel: 514-796-4067

Pharmascience